SHARIAH / WAM In a high-level meeting chaired by Sheikha Bodour Al Qasimi, the Board ...
Read More »Pfizer in talks to acquire sickle-cell drugmaker
Bloomberg Pfizer Inc is in advanced talks to buy Global Blood Therapeutics Inc., the maker of a therapy for sickle-cell disease, for about $5 billion, the Wall Street Journal (WSJ) reported. The New York-based drug giant is looking to finalise a deal in the coming days, the Journal reported. Bloomberg News had reported earlier this week that biotech was ...
Read More »